Alexander, G. Caleb http://orcid.org/0000-0002-5622-2986
Budnitz, Daniel
Hughes, Carmel
Maas, Renke
Mair, Alpana
McDonald, Emily G.
Meid, Andreas D.
Payne, Rupert
Seidling, Hanna M.
Shakir, Saad
Suissa, Samy
Tannenbaum, Cara
Schneeweiss, Sebastian
Dreischulte, Tobias
Article History
Accepted: 5 October 2023
First Online: 2 November 2023
Declarations
:
: No sources of funding were used to assist in the preparation of this work.
: G. Caleb Alexander is past Chair of the US FDA’s Peripheral and Central Nervous System Advisory Committee and a co-founding Principal and equity holder in Stage Analytics. Sebastian Schneeweiss (ORCID ID: 0000-0003-2575-467X) is participating in investigator-initiated grants to the Brigham and Women’s Hospital from Boehringer Ingelheim, Takeda, and UCB, unrelated to the topic of this study. He is a consultant to Aetion Inc., a software manufacturer of which he owns equity, and is also an advisor to Temedica GmbH, a patient-oriented data generation company. His interests were declared, reviewed, and approved by the Brigham and Women’s Hospital in accordance with their institutional compliance policies. Daniel Budnitz, Carmel Hughes, Renke Maas, Alpana Mair, Emily G. McDonald, Andreas D. Meid, Rupert Payne, Hanna M. Seidling, Saad Shakir, Samy Suissa, Cara Tannenbaum, and Tobias Dreischulte have no potential conflicts of interest relevant to the contents of this study.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
: Not applicable.
: GCA and TD conceived the report and drafted the manuscript. All authors contributed to substantive revisions of the manuscript and approved the final version and the decision to submit for publication.